These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 19336509

  • 1. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light.
    Khazai NB, Judd SE, Jeng L, Wolfenden LL, Stecenko A, Ziegler TR, Tangpricha V.
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2037-43. PubMed ID: 19336509
    [Abstract] [Full Text] [Related]

  • 2. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB, Kimber C, Mahnken JD, Stubbs JR.
    Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
    [Abstract] [Full Text] [Related]

  • 3. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.
    Fisk CM, Theobald HE, Sanders TA.
    J Nutr; 2012 Jul; 142(7):1286-90. PubMed ID: 22623396
    [Abstract] [Full Text] [Related]

  • 4. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P, Kiely PD.
    Scand J Rheumatol; 2009 Jul; 38(2):149-53. PubMed ID: 18991184
    [Abstract] [Full Text] [Related]

  • 5. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.
    Simoneau T, Sawicki GS, Milliren CE, Feldman HA, Gordon CM.
    J Cyst Fibros; 2016 Mar; 15(2):234-41. PubMed ID: 26211605
    [Abstract] [Full Text] [Related]

  • 6. Relative Efficacy of Vitamin D2 and Vitamin D3 in Improving Vitamin D Status: Systematic Review and Meta-Analysis.
    Balachandar R, Pullakhandam R, Kulkarni B, Sachdev HS.
    Nutrients; 2021 Sep 23; 13(10):. PubMed ID: 34684328
    [Abstract] [Full Text] [Related]

  • 7. Serum 24,25-dihydroxyvitamin D3 response to native vitamin D2 and D3 Supplementation in patients with chronic kidney disease on hemodialysis.
    Graeff-Armas LA, Kaufmann M, Lyden E, Jones G.
    Clin Nutr; 2018 Jun 23; 37(3):1041-1045. PubMed ID: 28506446
    [Abstract] [Full Text] [Related]

  • 8. Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency.
    Melhem SJ, Aiedeh KM, Hadidi KA.
    Ann Saudi Med; 2015 Jun 23; 35(1):13-8. PubMed ID: 26142932
    [Abstract] [Full Text] [Related]

  • 9. Case report: Three patients with substantial serum levels of 3-epi-25(OH)D including one with 3-epi-25(OH)D2 while on high-dose ergocalciferol.
    Wiebe D, Binkley N.
    J Clin Endocrinol Metab; 2014 Apr 23; 99(4):1117-21. PubMed ID: 24476080
    [Abstract] [Full Text] [Related]

  • 10. Effect of high dose vitamin D3 therapy on serum vitamin D3 levels in vitamin D insufficient adults with cystic fibrosis.
    Regalado Lam Chew Tun R, Porhownik N, Taback S, Oleschuk C.
    Clin Nutr ESPEN; 2018 Feb 23; 23():84-88. PubMed ID: 29460819
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D(3) is more potent than vitamin D(2) in humans.
    Heaney RP, Recker RR, Grote J, Horst RL, Armas LA.
    J Clin Endocrinol Metab; 2011 Mar 23; 96(3):E447-52. PubMed ID: 21177785
    [Abstract] [Full Text] [Related]

  • 12. Prospective, Randomized, Double-Blind, Parallel-Group, Comparative Effectiveness Clinical Trial Comparing a Powder Vehicle Compound of Vitamin D With an Oil Vehicle Compound in Adults With Cystic Fibrosis.
    Hermes WA, Alvarez JA, Lee MJ, Chesdachai S, Lodin D, Horst R, Tangpricha V.
    JPEN J Parenter Enteral Nutr; 2017 Aug 23; 41(6):952-958. PubMed ID: 26903303
    [Abstract] [Full Text] [Related]

  • 13. Daily supplementation with 15 μg vitamin D2 compared with vitamin D3 to increase wintertime 25-hydroxyvitamin D status in healthy South Asian and white European women: a 12-wk randomized, placebo-controlled food-fortification trial.
    Tripkovic L, Wilson LR, Hart K, Johnsen S, de Lusignan S, Smith CP, Bucca G, Penson S, Chope G, Elliott R, Hyppönen E, Berry JL, Lanham-New SA.
    Am J Clin Nutr; 2017 Aug 23; 106(2):481-490. PubMed ID: 28679555
    [Abstract] [Full Text] [Related]

  • 14. Vitamin D3 seems more appropriate than D2 to sustain adequate levels of 25OHD: a pharmacokinetic approach.
    Oliveri B, Mastaglia SR, Brito GM, Seijo M, Keller GA, Somoza J, Diez RA, Di Girolamo G.
    Eur J Clin Nutr; 2015 Jun 23; 69(6):697-702. PubMed ID: 25782422
    [Abstract] [Full Text] [Related]

  • 15. Evaluating Vitamin D Repletion Regimens and Effects in Veteran Patients.
    Aterrado S, Ono G, Kanehira-Mar S, Meier J, Swislocki A.
    Ann Pharmacother; 2015 Sep 23; 49(9):969-77. PubMed ID: 26104054
    [Abstract] [Full Text] [Related]

  • 16. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
    Glendenning P, Chew GT, Inderjeeth CA, Taranto M, Fraser WD.
    Bone; 2013 Oct 23; 56(2):271-5. PubMed ID: 23792937
    [Abstract] [Full Text] [Related]

  • 17. Vitamin-D2 treatment-associated decrease in 25(OH)D3 level is a reciprocal phenomenon: a randomized controlled trial.
    Hammami MM, Abuhdeeb K, Hammami S, Yusuf A.
    BMC Endocr Disord; 2019 Jan 18; 19(1):8. PubMed ID: 30658603
    [Abstract] [Full Text] [Related]

  • 18. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.
    Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, Carnevale V, Scillitani A, Minisola S.
    J Clin Endocrinol Metab; 2008 Aug 18; 93(8):3015-20. PubMed ID: 18492750
    [Abstract] [Full Text] [Related]

  • 19. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
    Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT, Tangpricha V.
    Endocr Pract; 2008 Aug 18; 14(1):10-7. PubMed ID: 18238736
    [Abstract] [Full Text] [Related]

  • 20. A PROSPECTIVE STUDY OF COMMONLY UTILIZED REGIMENS OF VITAMIN D REPLACEMENT AND MAINTENANCE THERAPY IN ADULTS.
    Rafii DC, Ali F, Farag A, Iyer B, Otterbeck PE, Chaudhari R, Potter N, Stefanov DG, Guber HA.
    Endocr Pract; 2019 Jan 18; 25(1):6-15. PubMed ID: 30383486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.